Renaissance Technologies

Renaissance Technologies’s Enliven Therapeutics ELVN Stock Holding History

Renaissance Technologies’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-59,000	Closed	-$1.21M	–	3372
2025 Q3	$1.21M	Buy	59,000 +35,100	+147%	+$708K	﹤0.01%	2391
2025 Q2	$479K	Buy	23,900 +12,000	+101%	+$227K	﹤0.01%	2851
2025 Q1	$234K	Buy	+11,900	New	+$256K	﹤0.01%	3028
2023 Q3	–	Sell	-36,150	Closed	-$738K	–	3761
2023 Q2	$738K	Sell	36,150 -34,108	-49%	-$689K	﹤0.01%	2665
2023 Q1	$1.54M	Buy	70,258 +16,808	+31%	+$342K	﹤0.01%	2194
2022 Q4	$874K	Sell	53,450 -28,881	-35%	-$462K	﹤0.01%	2609
2022 Q3	$751K	Sell	82,331 -19,549	-19%	-$115K	﹤0.01%	2667
2022 Q2	$497K	Sell	101,880 -10,745	-10%	-$52.6K	﹤0.01%	3169
2022 Q1	$847K	Buy	112,625 +2,725	+2%	+$18K	﹤0.01%	2835
2021 Q4	$989K	Buy	109,900 +41,325	+60%	+$542K	﹤0.01%	2645
2021 Q3	$1.12M	Buy	68,575 +58,633	+590%	+$1.22M	﹤0.01%	2485
2021 Q2	$314K	Buy	+9,942	New	+$308K	﹤0.01%	3133
2020 Q4	–	Sell	-3,056	Closed	-$249K	–	3456
2020 Q3	$249K	Sell	3,056 -191	-6%	-$17.2K	﹤0.01%	3057
2020 Q2	$359K	Buy	+3,247	New	+$363K	﹤0.01%	2983

Other funds holding ELVN

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return